Algenis specializes in the production, formulation, and clinical development of bioactive molecules produced by marine microalgae with medical application as muscle relaxant and analgesic, as well as for the treatment of neurological diseases.
Algenis was last modified: September 21st, 2018 by Editor
The 2023 LAVCA Startup Founders Survey is made possible thanks to the support of LAVCA’s Tech Growth Membership, a group of leading tech companies and investors advancing the tech ecosystem in Latin America including AWS, Mercado Libre, Microsoft, Qualcomm Ventures, SVB, Riverwood Capital, Google and Movile.
VC Partner Events
Tweets
Congratulations to all the winners of the 9th annual LAVCA ESG Deal Awards!
Learn more about the winners here:… https://t.co/VSLSO2QDkU
